About Moshira
Decoding Cancer, Layer by Layer
Moshira integrates multiomics data and artificial intelligence to reveal the full molecular picture of cancer — enabling precision medicine at scale.
Our Mission
Making Precision Medicine Accessible
We believe every patient deserves treatment guided by a complete molecular understanding of their disease. Moshira was founded to close the gap between cutting-edge research and clinical practice — by building AI systems that unify genomic, proteomic, epigenomic, and metabolomic data into a single, actionable profile.
Our Values
What We Stand For
Scientific Rigor
Every algorithm, every pipeline, every insight is peer-reviewed and clinically validated before it reaches a patient.
Patient First
We measure success by patient outcomes, not revenue. Every decision we make starts with the question: does this improve care?
Open Science
We publish our methods, share datasets, and contribute to the global research community. Transparency builds trust.
Security by Default
HIPAA, GDPR, SOC 2 Type II — compliance isn't a feature, it's the foundation. Your data never leaves a secure environment.
Our Journey
From Idea to Impact
Moshira founded, first multiomics prototype
Seed round, first hospital partnership
SOC 2 certification, 10 active clients
Series A, Omics Engine v2 launch
50+ research institutions, 86 publications
200+ cancer types covered, real-time processing
Leadership
The People Behind Moshira
Dr. Layla Hassan
CEO & Co-Founder
Former computational biology lead at Broad Institute. 15+ years in cancer genomics.
Dr. Marcus Chen
CTO & Co-Founder
Ex-Google Health AI. Built large-scale medical ML systems serving 100M+ patients.
Dr. Amira Patel
Chief Science Officer
Published 60+ papers in Nature, Cell, and NEJM. Expert in multi-omics integration.
James Okafor
VP of Engineering
Scaled distributed systems at AWS and Verily. Focused on real-time genomic pipelines.